{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:31Z","timestamp":1790627971560,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Walk Family","award":["1-R35-NS097211-01"],"award-info":[{"award-number":["1-R35-NS097211-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.expneurol.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T23:22:58Z","timestamp":1491520978000},"page":"270-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"PB","title":["Human stem cell modeling in neurofibromatosis type 1 (NF1)"],"prefix":"10.1016","volume":"299","author":[{"given":"Michelle L.","family":"Wegscheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Anastasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0005","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/nbt.1503","article-title":"Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes","volume":"26","author":"Aasen","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.stem.2011.07.002","article-title":"Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions","volume":"9","author":"Ambasudhan","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.expneurol.2017.04.001_bb0015","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.expneurol.2017.04.001_bb0020","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","article-title":"Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation","volume":"22","author":"Bajenaru","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.20337","article-title":"Natural history of neurofibromatosis 1-associated optic nerve glioma in mice","volume":"57","author":"Bajenaru","year":"2005","journal-title":"Ann. Neurol."},{"issue":"34","key":"10.1016\/j.expneurol.2017.04.001_bb0030","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","article-title":"Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells","volume":"9","author":"Bar-Nur","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1566523211313020002","article-title":"Technological overview of iPS induction from human adult somatic cells","volume":"13","author":"Bayart","year":"2013","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acn3.288","article-title":"A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I","volume":"3","author":"Bearden","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141597","article-title":"Comparison of mouse and human retinal pigment epithelium gene expression profiles: potential implications for age-related macular degeneration","volume":"10","author":"Bennis","year":"2015","journal-title":"PLoS One"},{"issue":"7346","key":"10.1016\/j.expneurol.2017.04.001_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","article-title":"Modelling schizophrenia using human induced pluripotent stem cells","volume":"473","author":"Brennand","year":"2011","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.expneurol.2017.04.001_bb0060","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.expneurol.2017.04.001_bb0065","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.12","article-title":"Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients","volume":"4","author":"Chen","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"issue":"6121","key":"10.1016\/j.expneurol.2017.04.001_bb0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"6871","key":"10.1016\/j.expneurol.2017.04.001_bb0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.expneurol.2017.04.001_bb0095","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/hmg\/ddm059","article-title":"Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth","volume":"16","author":"Daginakatte","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3164\/jcbn.15-39","article-title":"Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds","volume":"56","author":"Dai","year":"2015","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.23793","article-title":"Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice","volume":"73","author":"Diggs-Andrews","year":"2013","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"8","key":"10.1016\/j.expneurol.2017.04.001_bb0115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.5966\/sctm.2013-0192","article-title":"A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium","volume":"3","author":"Ferrer","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.expneurol.2017.04.001_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","article-title":"Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome","volume":"85","author":"Fusaki","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/dmcn.12043","article-title":"Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study","volume":"55","author":"Garg","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2013.00045","article-title":"Origin and differentiation of microglia","volume":"7","author":"Ginhoux","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"7336","key":"10.1016\/j.expneurol.2017.04.001_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature09805","article-title":"Somatic coding mutations in human induced pluripotent stem cells","volume":"471","author":"Gore","year":"2011","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.expneurol.2017.04.001_bb0140","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/sj.onc.1202829","article-title":"Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation","volume":"18","author":"Gutmann","year":"1999","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0145","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.61.10.1397","article-title":"Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1","volume":"61","author":"Gutmann","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0155","first-page":"920","article-title":"Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina","volume":"18","author":"Hambright","year":"2012","journal-title":"Mol. Vis."},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0160","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1128\/JVI.73.7.6141-6146.1999","article-title":"Frequency and stability of chromosomal integration of adenovirus vectors","volume":"73","author":"Harui","year":"1999","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","article-title":"Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms","volume":"1","author":"Hegedus","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","article-title":"Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.expneurol.2017.04.001_bb0175","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.expneurol.2017.04.001_bb0180","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1089\/scd.2013.0620","article-title":"All roads lead to induced pluripotent stem cells: the technologies of iPSC generation","volume":"23","author":"Hu","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2015.07.006","article-title":"Direct conversion of normal and Alzheimer's disease human fibroblasts into neuronal cells by small molecules","volume":"17","author":"Hu","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"18","key":"10.1016\/j.expneurol.2017.04.001_bb0190","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1242\/dev.118570","article-title":"Modeling mouse and human development using organoid cultures","volume":"142","author":"Huch","year":"2015","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0195","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.celrep.2012.12.013","article-title":"Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ","volume":"3","author":"Joo","year":"2013","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.expneurol.2017.04.001_bb0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"7313","key":"10.1016\/j.expneurol.2017.04.001_bb0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2010.06.017","article-title":"Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma","volume":"170","author":"Kim","year":"2010","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.expneurol.2017.04.001_bb0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"22","key":"10.1016\/j.expneurol.2017.04.001_bb0230","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1089\/scd.2014.0167","article-title":"Genomic editing tools to model human diseases with isogenic pluripotent stem cells","volume":"23","author":"Kim","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"7587","key":"10.1016\/j.expneurol.2017.04.001_bb0235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0245","first-page":"119","article-title":"A robust method to derive functional neural crest cells from human pluripotent stem cells","volume":"2","author":"Kreitzer","year":"2013","journal-title":"Am. J. Stem Cells"},{"issue":"16","key":"10.1016\/j.expneurol.2017.04.001_bb0250","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1093\/nar\/gku769","article-title":"Molecular mechanisms of retroviral integration site selection","volume":"42","author":"Kvaratskhelia","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch. Dermatol."},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0260","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"issue":"7467","key":"10.1016\/j.expneurol.2017.04.001_bb0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.expneurol.2017.04.001_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.applanim.2004.02.006","article-title":"From house mouse to mouse house: the behavioural biology of free-living Mus musculus and its implications in the laboratory","volume":"86","author":"Latham","year":"2004","journal-title":"Appl. Anim. Behav. Sci."},{"issue":"13","key":"10.1016\/j.expneurol.2017.04.001_bb0275","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1158\/0008-5472.CAN-10-4577","article-title":"Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development","volume":"71","author":"Le","year":"2011","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0280","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.stemcr.2015.04.002","article-title":"PSA-NCAM-negative neural crest cells emerging during neural induction of pluripotent stem cells cause mesodermal tumors and unwanted grafts","volume":"4","author":"Lee","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"21","key":"10.1016\/j.expneurol.2017.04.001_bb0285","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.expneurol.2017.04.001_bb0290","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4161\/cbt.10.8.12878","article-title":"Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Investig."},{"issue":"38","key":"10.1016\/j.expneurol.2017.04.001_bb0305","doi-asserted-by":"crossref","first-page":"61500","DOI":"10.18632\/oncotarget.11133","article-title":"The role of nerve microenvironment for neurofibroma development","volume":"7","author":"Liao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.expneurol.2017.04.001_bb0310","doi-asserted-by":"crossref","first-page":"794632","DOI":"10.1155\/2015\/794632","article-title":"Reprogramming with small molecules instead of exogenous transcription factors","volume":"2015","author":"Lin","year":"2015","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-014-0142-4","article-title":"The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial","volume":"9","author":"Lion-Francois","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0325","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/ncomms3183","article-title":"Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons","volume":"4","author":"Liu","year":"2013","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.expneurol.2017.04.001_bb0330","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2009-02-204800","article-title":"Generation of induced pluripotent stem cells from human blood","volume":"113","author":"Loh","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0335","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cell.2011.06.030","article-title":"Development and evolution of the human neocortex","volume":"146","author":"Lui","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.expneurol.2017.04.001_bb0345","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","article-title":"Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick type C patient-specific iPS cells","volume":"2","author":"Maetzel","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0350","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.stem.2008.08.003","article-title":"A high-efficiency system for the generation and study of human induced pluripotent stem cells","volume":"3","author":"Maherali","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0355","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0360","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2015.06.034","article-title":"FOXG1-dependent dysregulation of GABA\/glutamate neuron differentiation in autism spectrum disorders","volume":"162","author":"Mariani","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0365","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","article-title":"Direct lineage conversion of terminally differentiated hepatocytes to functional neurons","volume":"9","author":"Marro","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.expneurol.2017.04.001_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071000","article-title":"Site-specific genome engineering in human pluripotent stem cells","volume":"17","author":"Merkert","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0380","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrn.2016.46","article-title":"Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience","volume":"17","author":"Mertens","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0385","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nn.2817","article-title":"Hanging by the tail: progenitor populations proliferate","volume":"14","author":"Molnar","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.expneurol.2017.04.001_bb0390","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","article-title":"Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the International NF1-ASD Consortium Team (INFACT)","volume":"73","author":"Morris","year":"2016","journal-title":"JAMA Psychiat."},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/genes7100077","article-title":"Modeling fragile X syndrome using human pluripotent stem cells","volume":"7","author":"Mor-Shaked","year":"2016","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0400","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/nm.4189","article-title":"Efficient derivation of microglia-like cells from human pluripotent stem cells","volume":"22","author":"Muffat","year":"2016","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0405","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.stemcr.2015.01.006","article-title":"Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition","volume":"4","author":"Nori","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"6","key":"10.1016\/j.expneurol.2017.04.001_bb0410","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/stem.2356","article-title":"Stepwise differentiation of retinal ganglion cells from human pluripotent stem cells enables analysis of glaucomatous neurodegeneration","volume":"34","author":"Ohlemacher","year":"2016","journal-title":"Stem Cells"},{"issue":"7359","key":"10.1016\/j.expneurol.2017.04.001_bb0415","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10202","article-title":"Induction of human neuronal cells by defined transcription factors","volume":"476","author":"Pang","year":"2011","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.expneurol.2017.04.001_bb0420","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1212\/WNL.0000000000003435","article-title":"Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1","volume":"87","author":"Payne","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0425","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1037\/neu0000262","article-title":"Theory of mind in children with neurofibromatosis type 1","volume":"30","author":"Payne","year":"2016","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.23813","article-title":"Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation","volume":"73","author":"Pong","year":"2013","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0435","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0440","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/nm.4214","article-title":"The promises and challenges of human brain organoids as models of neuropsychiatric disease","volume":"22","author":"Quadrato","year":"2016","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2017.04.001_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161969","article-title":"Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes","volume":"11","author":"Raja","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0450","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","article-title":"Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression","volume":"12","author":"Reinhardt","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.expneurol.2017.04.001_bb0455","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.expneurol.2017.04.001_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071855","article-title":"Engrafted human induced pluripotent stem cell-derived anterior specified neural progenitors protect the rat crushed optic nerve","volume":"8","author":"Satarian","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0465","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nprot.2012.015","article-title":"Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus","volume":"7","author":"Seki","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2017.04.001_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0475","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1523\/JNEUROSCI.4773-10.2011","article-title":"Oblique radial glial divisions in the developing mouse neocortex induce self-renewing progenitors outside the germinal zone that resemble primate outer subventricular zone progenitors","volume":"31","author":"Shitamukai","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/NEN.0b013e3182032d37","article-title":"Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth","volume":"70","author":"Simmons","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0485","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","article-title":"The human side of microglia","volume":"37","author":"Smith","year":"2014","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0490","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.expneurol.2017.04.001_bb0495","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","article-title":"RNA sequencing of tumor-associated microglia reveals Ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth","volume":"17","author":"Solga","year":"2015","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.expneurol.2017.04.001_bb0500","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.stemcr.2013.11.006","article-title":"Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells","volume":"2","author":"Sugiura","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0505","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0510","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"1680","key":"10.1016\/j.expneurol.2017.04.001_bb0515","first-page":"20140368","article-title":"Direct somatic lineage conversion","volume":"370","author":"Tanabe","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"6","key":"10.1016\/j.expneurol.2017.04.001_bb0520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2340\/00015555-1843","article-title":"Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing","volume":"94","author":"Uusitalo","year":"2014","journal-title":"Acta Derm. Venereol."},{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0525","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1474-4422(13)70227-8","article-title":"Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial","volume":"12","author":"van der Vaart","year":"2013","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0530","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/WNL.0000000000002118","article-title":"Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1","volume":"86","author":"van der Vaart","year":"2016","journal-title":"Neurology"},{"issue":"7284","key":"10.1016\/j.expneurol.2017.04.001_bb0535","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.expneurol.2017.04.001_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125631","article-title":"A comparison of some organizational characteristics of the mouse central retina and the human macula","volume":"10","author":"Volland","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.expneurol.2017.04.001_bb0545","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H","article-title":"Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors","volume":"27","author":"Wallace","year":"2000","journal-title":"Genes Chromosom. Cancer"},{"issue":"22","key":"10.1016\/j.expneurol.2017.04.001_bb0550","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.biomaterials.2011.03.070","article-title":"Induced pluripotent stem cells for neural tissue engineering","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.expneurol.2017.04.001_bb0555","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"7239","key":"10.1016\/j.expneurol.2017.04.001_bb0560","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.expneurol.2017.04.001_bb0565","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1101\/gr.173427.114","article-title":"Seamless gene correction of beta-thalassemia mutations in patient-specific iPSCs using CRISPR\/Cas9 and piggyBac","volume":"24","author":"Xie","year":"2014","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.expneurol.2017.04.001_bb0570","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212- and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.expneurol.2017.04.001_bb0575","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1089\/scd.2015.0137","article-title":"Enhanced rejuvenation in induced pluripotent stem cell-derived neurons compared with directly converted neurons from an aged mouse","volume":"24","author":"Yang","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"7255","key":"10.1016\/j.expneurol.2017.04.001_bb0580","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature08139","article-title":"MicroRNA-mediated switching of chromatin-remodelling complexes in neural development","volume":"460","author":"Yoo","year":"2009","journal-title":"Nature"},{"issue":"7359","key":"10.1016\/j.expneurol.2017.04.001_bb0585","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature10323","article-title":"MicroRNA-mediated conversion of human fibroblasts to neurons","volume":"476","author":"Yoo","year":"2011","journal-title":"Nature"},{"issue":"5858","key":"10.1016\/j.expneurol.2017.04.001_bb0590","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"5928","key":"10.1016\/j.expneurol.2017.04.001_bb0595","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.expneurol.2017.04.001_bb0600","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/stem.201","article-title":"Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells","volume":"27","author":"Zhou","year":"2009","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0605","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1681\/ASN.2011010106","article-title":"Generation of induced pluripotent stem cells from urine","volume":"22","author":"Zhou","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.expneurol.2017.04.001_bb0610","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev."},{"issue":"5569","key":"10.1016\/j.expneurol.2017.04.001_bb0615","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.expneurol.2017.04.001_bb0620","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1242\/dev.02162","article-title":"Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation","volume":"132","author":"Zhu","year":"2005","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.expneurol.2017.04.001_bb0625","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.stem.2010.11.015","article-title":"Reprogramming of human primary somatic cells by OCT4 and chemical compounds","volume":"7","author":"Zhu","year":"2010","journal-title":"Cell Stem Cell"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:49:55Z","timestamp":1758001795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":125,"alternative-id":["S0014488617300948"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human stem cell modeling in neurofibromatosis type 1 (NF1)","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}